Literature DB >> 6806371

Separable helper factors support B cell proliferation and maturation to Ig secretion.

D C Parker.   

Abstract

The 24-hr culture supernatant of Con A-activated spleen cells (SN) contains helper factors that enable maturation to high-rate polyclonal Ig secretion and enhance proliferation in cultures of mouse B cells activated with the F(ab')2 fragment of class-specific rabbit antimouse IgM antibody (anti-Ig). When interleukin 2 (IL 2), also called T cell growth factor, is removed from SN by absorption with an IL 2-dependent cell line at either 4 degrees C or 37 degrees C, all the helper activity for anti-Ig-activated B cells is also removed. Partial removal of IL 2 results in partial removal of helper activity for B cells. However, the IL 2-depleted SN appears to contain another helper factor, TRF, that enables anti-Ig-activated B cell cultures to mature to high-rate Ig secretion. This TRF activity is revealed by adding purified human IL 2 or an IL 2-containing supernatant of a cloned, lectin-activated T cell hybridoma line (FS6-14.13) to Il 2-depleted SN, which restores the polyclonal antibody response to anti-Ig. The hybridoma supernatant by itself supports proliferation of anti-Ig-activated B cell cultures, as measured by an increase in cell number, but not maturation to Ig secretion. This proliferative response is likewise IL 2 dependent, although purified IL 2 with anti-Ig is not sufficient. These experiments define separable combinations of factors acting on anti-Ig-activated B cell cultures, one of which (SN) results in both proliferation and maturation to high-rate Ig secretion, whereas the other (hybridoma supernatant) results in proliferation only. IL 2 appears to be an essential component of both combinations, although the target cell for IL 2 action in this system remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6806371

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

1.  Differential mechanism for differentiation into immunoglobulin-secreting cells in human resting B lymphocyte subsets isolated on the basis of cell density.

Authors:  N Suzuki; Y Ueda; T Sakane
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

2.  Modulation of immunoglobulin production and cytokine mRNA expression in peripheral blood mononuclear cells by intravenous immunoglobulin.

Authors:  M Toyoda; X Zhang; A Petrosian; O A Galera; S J Wang; S C Jordan
Journal:  J Clin Immunol       Date:  1994-05       Impact factor: 8.317

3.  Proliferative responsiveness of B cells from autoimmune NZB mice to anti-immunoglobulin and interleukin-4.

Authors:  M Hatakeyama; N Minato; S Kano
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

4.  Dissociation of murine B-cell proliferation and differentiation by monoclonal antibody, NIM R2.

Authors:  S Marshall-Clarke; J Harrison; R M Parkhouse
Journal:  Immunology       Date:  1986-02       Impact factor: 7.397

5.  IgM RNA switch from membrane to secretory form is prevented by adding antireceptor antibody to bacterial lipopolysaccharide-stimulated murine primary B-cell cultures.

Authors:  U Chen-Bettecken; E Wecker; A Schimpl
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

6.  Identification of a unique B-cell-stimulating factor produced by a cloned dendritic cell.

Authors:  C Clayberger; R H DeKruyff; R Fay; H Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

7.  In-vitro analysis of defective IgA production in selective IgA deficiency in childhood.

Authors:  N Shinomiya; J Yata
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

8.  Differential ability of B cells specific for external vs. internal influenza virus proteins to respond to help from influenza virus-specific T-cell clones in vivo.

Authors:  P A Scherle; W Gerhard
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

9.  Both interleukin 2 and a second T cell-derived factor in EL-4 supernatant have activity as differentiation factors in IgM synthesis.

Authors:  K Nakanishi; T R Malek; K A Smith; T Hamaoka; E M Shevach; W E Paul
Journal:  J Exp Med       Date:  1984-12-01       Impact factor: 14.307

10.  The IL-2/CD25 pathway determines susceptibility to T1D in humans and NOD mice.

Authors:  Calliope A Dendrou; Linda S Wicker
Journal:  J Clin Immunol       Date:  2008-09-09       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.